Clinical Trial: A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: ADHD
Study Type: INTERVENTIONAL
Official Title: A Phase 3, Randomized, Double-blind, Placebo-controlled Trial of Solriamfetol in Adults With ADHD.
Brief Summary:
FOCUS (Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol) is a Phase 3, multi-center, randomized, double-blind, placebo-controlled, parallel- group trial to assess the efficacy and safety of solriamfetol in adults with ADHD.
Read more